Literature DB >> 18687398

G protein-coupled receptor kinase 6 controls post-inflammatory visceral hyperalgesia.

Niels Eijkelkamp1, Cobi J Heijnen, Sigrid Elsenbruch, Gerald Holtmann, Manfred Schedlowski, Annemieke Kavelaars.   

Abstract

Post-inflammatory pain is a poorly understood phenomenon. G protein-coupled receptors are involved in regulating pain signaling in the context of inflammation. G protein-coupled receptor kinases (GRK) modulate signaling through these receptors. We investigated whether GRK6 contributes to post-inflammatory visceral hyperalgesia. Colitis was induced in female mice by 1% dextran sodium sulphate in drinking water for 7 days. Disease score, colon length, and colonic cytokines were determined. On day 49, when animals had recovered from colitis, we induced visceral pain by intracolonic capsaicin instillation. Behavioral responses to capsaicin were monitored for 20 min. Referred hyperalgesia was measured using von Frey hairs. Spinal cord c-Fos was visualized by immunohistochemistry. In contrast to our earlier observations in male GRK6-/- and wild type (WT) mice, we did not detect differences in the course of colitis or in expression of colonic cytokines between female GRK6-/- and WT mice. After recovery from colitis, capsaicin-induced behavioral pain responses and spinal cord c-Fos expression were more pronounced in female GRK6-/- than WT mice. Naive GRK6-/- and WT animals did not differ in pain and c-Fos responses to capsaicin. Capsaicin-induced referred hyperalgesia post-colitis was increased in GRK6-/- compared to WT mice. However, referred hyperalgesia post-colitis was not affected by ablation of GRK6. Furthermore, in vitro IL-1beta sensitized the capsaicin receptor TRPV1 and this process was inhibited by over-expression of GRK6. We describe the novel concept that GRK6 inhibits post-inflammatory visceral hyperalgesia but does not contribute to visceral pain in naive animals. We propose that GRK6 regulates inflammation-induced sensitization of TRPV1.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18687398     DOI: 10.1016/j.bbi.2008.07.006

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  10 in total

1.  Neutrophil Elastase Activates Protease-activated Receptor-2 (PAR2) and Transient Receptor Potential Vanilloid 4 (TRPV4) to Cause Inflammation and Pain.

Authors:  Peishen Zhao; TinaMarie Lieu; Nicholas Barlow; Silvia Sostegni; Silke Haerteis; Christoph Korbmacher; Wolfgang Liedtke; Nestor N Jimenez-Vargas; Stephen J Vanner; Nigel W Bunnett
Journal:  J Biol Chem       Date:  2015-04-15       Impact factor: 5.157

2.  Role of G protein-coupled receptor kinase-6 in Escherichia coli lung infection model in mice.

Authors:  Taehyung Lee; Nandakumar Packiriswamy; Eunhee Lee; Peter C Lucas; Laura R McCabe; Narayanan Parameswaran
Journal:  Physiol Genomics       Date:  2017-09-22       Impact factor: 3.107

Review 3.  Systematic review of animal models of post-infectious/post-inflammatory irritable bowel syndrome.

Authors:  Hong-Yan Qin; Justin C Y Wu; Xu-Dong Tong; Joseph J Y Sung; Hong-Xi Xu; Zhao-Xiang Bian
Journal:  J Gastroenterol       Date:  2010-09-17       Impact factor: 7.527

4.  Expression of G-protein-coupled receptor kinase 6 (GRK6) after acute spinal cord injury in adult rat.

Authors:  Binbin Sun; Yilu Gao; Dong Lou; Xiujie Wu; Haixiang Wei; Hai Wen; Xiaolong Deng; Feng Zhang
Journal:  J Mol Histol       Date:  2013-01-29       Impact factor: 2.611

5.  Decreased expression and role of GRK6 in spinal cord of rats after chronic constriction injury.

Authors:  Yuan Zhou; Xiaodong Huang; Hao Wu; Yue Xu; Tao Tao; Guangfei Xu; Chun Cheng; Su Cao
Journal:  Neurochem Res       Date:  2013-08-25       Impact factor: 3.996

6.  G protein-coupled receptor kinase 6 acts as a critical regulator of cytokine-induced hyperalgesia by promoting phosphatidylinositol 3-kinase and inhibiting p38 signaling.

Authors:  Niels Eijkelkamp; Cobi J Heijnen; Anibal Garza Carbajal; Hanneke L D M Willemen; Huijing Wang; Michael S Minett; John N Wood; Manfred Schedlowski; Robert Dantzer; Keith W Kelley; Annemieke Kavelaars
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

7.  A low dose of fermented soy germ alleviates gut barrier injury, hyperalgesia and faecal protease activity in a rat model of inflammatory bowel disease.

Authors:  Lara Moussa; Valérie Bézirard; Christel Salvador-Cartier; Valérie Bacquié; Corinne Lencina; Mathilde Lévêque; Viorica Braniste; Sandrine Ménard; Vassilia Théodorou; Eric Houdeau
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

8.  Understanding and targeting centrally mediated visceral pain in inflammatory bowel disease.

Authors:  Kristen E Farrell; Robert J Callister; Simon Keely
Journal:  Front Pharmacol       Date:  2014-03-05       Impact factor: 5.810

9.  Characterization of the G protein-coupled receptor kinase 6 promoter reveals a functional CREB binding site.

Authors:  Maike Stegen; Andrea Engler; Crista Ochsenfarth; Iris Manthey; Jürgen Peters; Winfried Siffert; Ulrich H Frey
Journal:  PLoS One       Date:  2021-02-18       Impact factor: 3.240

10.  Overexpression of GRK6 attenuates neuropathic pain via suppression of CXCR2 in rat dorsal root ganglion.

Authors:  Yuan Zhou; Rong-Ji Li; Meng Li; Xuelian Liu; Hong-Yan Zhu; Zhong Ju; Xiuhua Miao; Guang-Yin Xu
Journal:  Mol Pain       Date:  2016-05-04       Impact factor: 3.395

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.